Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 4 6 2024
Statut: ppublish

Résumé

Background Retrospective studies have suggested that using artificial intelligence (AI) may decrease the workload of radiologists while preserving mammography screening performance. Purpose To compare workload and screening performance for two cohorts of women who underwent screening before and after AI system implementation. Materials and Methods This retrospective study included 50-69-year-old women who underwent biennial mammography screening in the Capital Region of Denmark. Before AI system implementation (October 1, 2020, to November 17, 2021), all screenings involved double reading. For screenings conducted after AI system implementation (November 18, 2021, to October 17, 2022), likely normal screenings (AI examination score ≤5 before May 3, 2022, or ≤7 on or after May 3, 2022) were single read by one of 19 senior full-time breast radiologists. The remaining screenings were read by two radiologists with AI-assisted decision support. Biopsy and surgical outcomes were retrieved between October 1, 2020, and April 15, 2023, ensuring at least 180 days of follow-up. Screening metrics were compared using the χ

Identifiants

pubmed: 38832880
doi: 10.1148/radiol.232479
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e232479

Auteurs

Andreas D Lauritzen (AD)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Martin Lillholm (M)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Elsebeth Lynge (E)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Mads Nielsen (M)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Nico Karssemeijer (N)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Ilse Vejborg (I)

From the Departments of Computer Science (A.D.L., M.L., M.N.) and Public Health (E.L.), University of Copenhagen, Copenhagen, Denmark; Department of Breast Examinations, Gentofte Hospital, Kildegårdsvej 30A, 2900 Hellerup, Denmark (A.D.L., I.V.); Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands (N.K.); and ScreenPoint Medical, Nijmegen, the Netherlands (N.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH